Making the paper: Sakari Kauppinen.

The article outlines the research conducted by Sakari Kauppinen and colleagues regarding the impact RNA molecules in HØrsholm, Denmark. They collaborated with RxGen and Standford University in California wherein they have successfully blocked the activity of one type of microRNA in non-human primates and the compound they developed is a potential treatment for hepatitis C. It also reveals that microRNAs regulate protein synthesis by binding to the messenger RNAs that provide the recipe for protein construction, repressing the relevant protein's production.